Anixa Biosciences presents at Cantor Fitzgerald Global Healthcare Conference on breast cancer vaccine progress

Reuters2026/08/24 12:55

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Anixa Biosciences will attend the 2026 Cantor Fitzgerald Global Healthcare Conference in New York on Sept. 9-11, 2026.
A management presentation is scheduled for Sept. 11, 2026 at 8:00 a.m. ET.
Update will cover Phase 1 breast cancer vaccine results, with immune responses in 74% of participants.
Discussion will also include lira-cel ovarian cancer CAR-T dosing in the fifth cohort, with no dose-limiting toxicities reported.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Anixa Biosciences Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608240855PR_NEWS_USPR_____LA31702) on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Anixa Biosciences presents at Cantor Fitzgerald Global Healthcare Conference on breast cancer vaccine progress

You may also like

Crypto prices